Longevity app 101+ launches in Little Rock

With advances in science and health and thanks to the growing advent of artificial intelligence (AI), a Little Rock tech firm and regional hospital unveiled Monday (April 7) a new app, 101+, they hope will revolutionize life spans and longevity.

101+ is a personalized longevity platform developed by Arkansas Heart Hospital and BOND.AI, a Little Rock-based, award-winning AI company founded by Uday Akkaraju.

The 101+ app takes blood work drawn at a laboratory and analyzes over 150 biomarkers and 500 data points to provide a picture of a person’s health at a molecular and cellular health level. With that knowledge, future health risks can be assessed, root causes of health problems can be identified, and a “journey to fix the root cause” of health issues can be developed.

“By bringing together data, health experts, and our Empathy Engine AI Technology, 101+ is the world’s first hyper-personalized longevity app,” said Akkaraju at a news conference held Monday at the Little Rock Regional Chamber of Commerce. “One of the biggest concerns for families today is quality of life, and this app appeases that exact concern. By redefining longevity holistically, we’re turning back the clock on aging with life-changing potential.”

After downloading the 101+ app and choosing from a two-tiered subscription plan, users schedule a blood test appointment through Arkansas Heart Hospital, based in Little Rock. The samples are analyzed in two specialized laboratories, and comprehensive results are delivered securely through the app.

“Aging is not the same in all people,” said Dr. Bruce Murphy, a world-leading cell biologist, cardiologist, and CEO of the Arkansas Heart Hospital. “The biggest disease impacting Americans today is not heart disease or kidney disease, but rather the disease of aging.”

Describing the use of AI as a “Gutenberg moment” in reference to the printing press and how it changed education and life spans due to knowledge, communication, scientific advancements and empowerment, Murphy said 101+ identifies factors in each person to allow AI to help create programs and processes to monitor aging and slow down or reverse some of its effects. In many instances, the results of the app can help identify potential causes of sickness and allow people to change habits or fix problems before they happen.

In one example displayed at the news conference, an anonymous person’s results were shown that compared their chronological standing versus their biological standing. It showed that cellular aging was five years higher than the average for their age, while musculoskeletal aging was three years below the average for their age. AI can then be used to recommend possible habits to slow cellular aging, such as different nutritional habits, exercise or weight loss. Going forward, those changes can be measured for progress through 101+.

In the case of disease prevention, a person may be alerted to predispositions well ahead of them manifesting symptoms. The advanced knowledge could lead to early screening or changing habits that could minimize the disease.

Touting 101+ as ChatGPT for your health, the app uses the tag line that “your health span is rewritable. It is never too late.”

The proprietary algorithms of BOND.AI’s software crunches the data from the tests and biomarkers to extend human lifespans, it contends. “With personalized baselines and precision plans, 101+ helps you optimize every system in your body from cellular repair to metabolic performance so you can live stronger, longer,” a news release stated.

101+ starts at $999, which is less than some longevity clinic offerings that can range from $5,000 a year to as high as $250,000 for testing, results and consultations.